Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aratana Therapeutics Inc announces proposed public offering


Wednesday, 22 Jan 2014 04:22pm EST 

Aratana Therapeutics Inc:Says that it is commencing an underwritten registered public offering of 5,500,000 shares of its common stock.Says A total of 4,500,000 shares are being offered by Aratana Therapeutics, and a total of 1,000,000 shares are being offered by certain selling stockholders.Says a selling stockholder also intends to grant the underwriters a 30-day option to purchase up to a maximum of 825,000 additional shares of common stock.Jefferies LLC, Barclays, and William Blair will act as joint book-running managers for the offering.Says JMP Securities and Craig-Hallum Capital Group will act as co-managers. 

Company Quote

12.55
-0.01 -0.08%
24 Jul 2014